Advertisement

The Scientist

» opinion, immunology and disease/medicine

Most Recent

image: Deliberating Over Danger

Deliberating Over Danger

By | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2012

April 2012's selection of notable quotes

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: Opinion: Saving an Owl from Politics

Opinion: Saving an Owl from Politics

By | March 26, 2012

The imperiled northern spotted owl faces extinction if efforts enacted to save it continue to put politics ahead of science.

22 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: Let Them Eat Dirt

Let Them Eat Dirt

By | March 22, 2012

Early exposure to microbes shapes the mammalian immune system by subduing inflammatory T cells.

30 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Opinion: A Truly Public Lab?

Opinion: A Truly Public Lab?

By | March 21, 2012

Should the healthcare system support health and wellness data tracking for the purposes of long-term observational studies?

22 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Cell Sciences
Cell Sciences
Advertisement
Life Technologies